Home About us Contact
|
Home About us Contact | ||
|
|
||
Mixed Phases (mixed + phase)
Selected AbstractsSmall angle neutron scattering study of the structure and hydration of polyoxyethylene- block -polyoxybutylene in aqueous solutionPOLYMER INTERNATIONAL, Issue 7 2006J Patrick A Fairclough Abstract The micellar structure of a polyoxyethylene- block -polyoxybutylene diblock copolymer (E18B10; E = (OCH2CH2); B = OCH2CH(CH2CH3)) in water was studied by small angle neutron scattering. Results show a polydisperse spherical micelles at temperatures below 45 °C, a possible mixed phase at 45 °C and flexible worm-like micelles at 65 °C. The spherical micelles at 25 and 35 °C have radii of 39 and 40 Å and degrees of hydration of 28% and 26%, respectively. The worm-like micelles have a total length of approximately 1850 Å, with segment lengths of 123 Å, a core radius, Rax = 30 Å and hydration of 23%, at 65 °C. Copyright © 2006 Society of Chemical Industry [source] Psychotic phenomena in 257 young children and adolescents with bipolar I disorder: delusions and hallucinations (benign and pathological)BIPOLAR DISORDERS, Issue 1 2008Rebecca Tillman Objectives:, In contrast to studies of adult bipolar I disorder (BP-I), there is a paucity of data on psychotic phenomena in child BP-I. Therefore, the aim of this work was to describe delusions and hallucinations in pediatric BP-I. Methods:, Subjects were 257 participants, aged 6,16, in either of two large, ongoing, NIMH-funded studies, ,Phenomenology and Course of Pediatric Bipolar Disorders' or ,Treatment of Early Age Mania (TEAM)'. All subjects had current DSM-IV BP-I (manic or mixed phase) with a Children's Global Assessment Scale score ,60 (definite clinical impairment), and all had cardinal mania symptoms (i.e., elation and/or grandiosity). Comprehensive assessments included the Washington University in St. Louis Kiddie Schedule for Affective Disorders and Schizophrenia (WASH-U-KSADS), which was administered to parents about their children and separately to children about themselves by experienced research clinicians. The WASH-U-KSADS contains modules for developmentally child-age-specific manifestations of numerous categories of psychotic phenomena. Results:, Psychosis was present in 76.3% (n = 196) of subjects, which included 38.9% (n = 100) with delusions, 5.1% (n = 13) with pathological hallucinations, and 32.3% (n = 83) with both. The most common delusion was grandiose (67.7%, n = 174), and the most common pathological hallucination was visual (16.0%, n = 41). Benign hallucinations occurred in 43.6% (n = 112). A median split by age yielded 6,9 year-olds (n = 139) and 10,16 year-olds (n = 118). Analyses of these two groups, and of 6, 7, 8, and 9 year-olds separately, found no significant differences in psychotic phenomena. Conclusions:, Counterintuitively, psychosis was equally prevalent in 6,9 compared to 10,16 year-olds. High prevalence of psychosis in child BP-I warrants focus in intervention strategies and is consistent with increasing evidence of the severity of child-versus adult-onset BP-I. [source] Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double-blind, randomized, placebo-controlled study,,HUMAN PSYCHOPHARMACOLOGY: CLINICAL AND EXPERIMENTAL, Issue 2 2008Fabiano G. Nery Abstract Objective To investigate whether the cox-2 inhibitor celecoxib has antidepressant effects in bipolar disorder (BD) patients during depressive or mixed phases. Methods We studied 28 DSM-IV BD patients who were experiencing a depressive or mixed episode and were on a stable dose of a mood stabilizer or atypical antipsychotic medication. Subjects were randomized to receive 6 weeks of double-blind placebo or celecoxib (400,mg/day) treatment. Current mood stabilizer or antipsychotic medication remained at the same doses during the trial. Results Intention-to-treat analysis showed that the patients receiving celecoxib had lower Hamilton Depression Rating Scale (HamD) scores after 1 week of treatment compared to the patients receiving placebo, but this difference was not statistically significant (p,=,0.09). The improvement in the first week of treatment was statistically significant when the analysis included only the subjects who completed the full 6-week trial (p,=,0.03). The two groups did not differ significantly on depressive or manic symptoms from the second week until the end of the trial. Celecoxib was well tolerated with the exception of two subjects who dropped out of the study due to rash. Conclusions Our findings suggest that adjunctive treatment with celecoxib may produce a rapid-onset antidepressant effect in BD patients experiencing depressive or mixed episodes. Copyright © 2008 John Wiley & Sons, Ltd. [source] Zirconia,Silica,Carbon Coatings on Ceramic FibersJOURNAL OF THE AMERICAN CERAMIC SOCIETY, Issue 10 2004Emmanuel E. Boakye Precursors for zircon,carbon mixtures were made to coat fibers for ceramic-matrix composites. Precursors were characterized using XRD, TGA, and DTA. Zircon formed from vanadium- or lithium-doped precursors after heat treatments at ,900°C in air, but it did not form at 1200°,1400°C in argon when large amounts of carbon were added. Some precursors were used to coat NextelÔ 720 and Hi-NicalonÔ fibers. The coatings were characterized using SEM and TEM, and coated-fiber tensile strengths were measured. Although zircon formed in powders, only tetragonal-zirconia,silica mixed phases formed in fiber coatings at 1200°C in air. Loss of vanadium oxide flux to the fibers may have caused the lack of conversion to zircon. The strengths of the coated fibers were severely degraded after heat treatment at ,1000°C in air, but not in argon. The coated fibers were compared with zirconia,carbon-coated fibers made using similar methods. Mechanisms for fiber strength degradation are discussed. [source] Microstructure Characterizations in Calcium Magnesium NiobateJOURNAL OF THE AMERICAN CERAMIC SOCIETY, Issue 7 2001Hwack Joo Lee Microstructural studies on the domain boundaries in Ca(Mg1/3CNb2/3)O3 (CMN) complex perovskite compound were conducted using X-ray diffractometry and transmission electron microscopy. The 1:2 chemical ordering of B-site cations and the tilting of oxygen octahedra were involved in the CMN microstructure, as inferred from the presence of two types of domain boundaries. One type was the antiphase boundaries (APBs), which did not lie on a specific set of crystallographic planes. These boundaries were caused by the chemical 1:2 ordering of B-site cations, magnesium and niobium. The other type was the ferroelastic domain boundaries, which were parallel to a certain crystallographic plane. Therefore, CMN had the 1:2 ordered monoclinic unit cell distorted by the antiphase or in-phase tilting of oxygen octahedra. CMN had the mixed phases rather than the homogeneous phase. [source] Clinical predictors of unrecognized bipolar I and II disordersBIPOLAR DISORDERS, Issue 2 2008Outi Mantere Objectives:, Bipolar disorder (BD) is correctly diagnosed in only 40,50% of patients. No previous study has investigated the characteristics of bipolar patients in psychiatric care with or without clinical diagnoses of BD. We investigated the demographic and clinical predictors of the absence of a clinical diagnosis of BD I and II among psychiatric patients. Methods:, In the Jorvi Bipolar Study, 1,630 psychiatric in- and outpatients were screened with the Mood Disorder Questionnaire. Suspected cases were diagnosed with the Structured Clinical Interview for DSM-IV Axis I Disorders-Patient version (SCID-I/P) for BD. Patients with no preceding clinical diagnosis of BD, despite previous manic, hypomanic or mixed phases and treatment in psychiatric care, were classified as undiagnosed. The clinical characteristics of unrecognized BD I patients (23 of 90 BD I patients) and BD II patients (47 of 93 BD II patients) were compared to those of patients who had been correctly diagnosed. Results:, No previous hospitalizations [odds ratio (OR) = 10.6, p = 0.001] or psychotic symptoms (OR = 4.4, p = 0.045), and the presence of rapid cycling (OR = 11.6, p = 0.001) predicted lack of BD I diagnosis. No psychotic symptoms (OR = 3.3, p = 0.01), female gender (OR = 3.0, p = 0.03), and shorter time in treatment (OR = 1.1, p = 0.03) predicted the lack of a BD II diagnosis. Conclusions:, Correct diagnosis of BD I is related to the severe phases of illness leading to hospitalizations. In BD II, the illness factors may not be as important as time elapsed in treatment, a factor that often leads to a delay in diagnosis or none at all. Excessive reliance on typical and cross-sectional presentations of illness likely explain the non-recognition of BD. The challenge for correctly diagnosing bipolar patients is in outpatient settings. [source] Ketoconazole in bipolar patients with depressive symptoms: a case series and literature reviewBIPOLAR DISORDERS, Issue 1 2001E Sherwood Brown Background: Data from several studies suggest that medications, such as ketoconazole, which lower cortisol levels, may be effective for major depressive disorder (MDD). As with MDD, the manic, depressive, and mixed phases of bipolar disorder are frequently associated with elevated cortisol levels. The literature on the use of cortisol-lowering strategies in mood disorders is reviewed, and a case series illustrating the use of ketoconazole in bipolar depression is presented. Methods: For the review, the MEDLINE and PSYCHINFO databases were searched, as were the bibliographies of pertinent articles to find papers on the use of cortisol-lowering agents in patients with mood disorders. In our open-label case series (n=6), ketoconazole (up to 800 mg/day) as an add-on therapy was given to patients with treatment-resistant or intolerant bipolar I or II disorders with current symptoms of depression. Results: Several case reports and small open studies suggest that cortisol-lowering agents may be useful for patients with depression. Two recent placebo-controlled trials of ketoconazole on patients with MDD report conflicting results. In our case series, all three patients who received a dose of at least 400 mg/day had substantial reductions in depressive symptoms. None had significant increases in mania. However, cortisol levels were not lowered in any of the subjects. Conclusions: The literature suggests that cortisol-lowering medications may be effective for a subset of depressed patients. Our preliminary findings suggest that ketoconazole may be useful in some patients with bipolar depression. Larger clinical trials are needed to confirm our observations. [source] | |||||||||||||